All lobbying filings

Tiber Creek Group

Tiber Creek Group filed a Q3 report for Acadia Pharmaceuticals, Inc. on October 20, 2026, reporting $80,000 in lobbying income.

Lobbying for Acadia Pharmaceuticals, Inc. · Biopharmaceutical company.

As filed: TIBER CREEK GROUP for ACADIA PHARMACEUTICALS, INC.

All filings by Tiber Creek Group · Everything Acadia Pharmaceuticals, Inc. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$80,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to drug pricing; Issues related to the Inflation Reduction Act (PL 117-169).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.